oral chlorhexidine as preventative agent in of ventilator-associated pneumonia (VAP) in adults who are critically ill and mechanically ventilated in intensive care units (ICUs). The process of critiquing published studies leads to higher level of co Continue Reading...
Omit Titles and Degrees] Klompas M., Speck, K., Howell M.D., Greene, L.R., & Berenholtz, S.M. (2014). Reappraisal of routine oral care with chlorohexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analy Continue Reading...
Introduction Advances in medicine have resulted in the further enhancement of patient outcomes in healthcare settings. It is, however, important to note that the treatment of many patients in close proximity does have some downsides. Hospital acquire Continue Reading...
patients undergoing mechanical ventilation contract Ventilator Associated Pneumonia (VAP). This acute medical condition always results in increased death rates and associated medical costs among patients. This article reviews several literatures tha Continue Reading...
PICOT In critically ill adults (p), how does the daily use of chlorohexidine (I) compared to sterile water reduce VAP (ventilator-associated pneumonia) (O) during hospitalized stay (T). Part 2 Identifying a Problem Of the infections acquired by pa Continue Reading...
pneumonia is a recurrent mechanical ventilation complication affecting almost 25% of ventilated patients. This type of pneumonia is referred to as ventilator-associated pneumonia (VAP) and it accounts for up to 90% of nosocomial infections among the Continue Reading...
